Sonoma Biologics, a producer of high-quality, low-cost cannabis, utilizes organic products for both fertilization and pest management as part of its standard operating measures. The company is committed to adherence to stringent guidelines of both the Appellation of Origin and the OCal programs, which are designed to set California cannabis apart from that of other growth areas. “The soil at Sonoma Biologics main cultivation farm is Gold Ridge fine sandy loam. This local soil is known for its production of ultra-premium Pinot Noir grapes and wines,” reads a recent article discussing the company’s positioning. “Some of the most coveted Pinot Noirs produced in California are neighbors. The company believes that this soil, as well as the local microclimate, are major factors that contribute to the high quality of this appellation. ‘Participating in the CDFA, the California Department of Food and Agriculture, will ensure that customers who see the Sonoma designation on a product label will instantly understand they are getting the highest-quality, sun-grown, natural, pure product,’ said Paul Caracciolo, CEO of Sonoma Biologics. ‘For four years running, our cultivated product has passed the stringent state of CA laboratory quality control tests for purity.’”
To view the full article, visit https://ibn.fm/7UZg5
About Sonoma Biologics Corp.
Sonoma Biologics is an ultra-premium cannabis grower focused on the medicinal and recreational cannabis markets. The company is led by an experienced management team with a proven track record in the large-scale agriculture business for the last decade and entry into the cannabis business in the last three years. Management has established relationships with cannabis farming, processing, manufacturing and retail partners throughout California. For more information, visit the company’s website at www.OwnSonomaBiologics.com.
NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.